Диланубицел

Rec. INN (наименование, зарегистрированное ВОЗ)

USAN (наименование, принятое к употреблению в США)

404719594

Allogeneic umbilical cord CD34⁺ enriched blood cells. The drug substance consists of the total progeny generated from culture of enriched CD34⁺ umbilical cord blood cells that have been cultured ex vivo in the presence of immobilised engineered Notch ligand Delta1ext -IgG (DXI) and recombinant cytokines. Cell phenotype distribution: CD3, CD7, CD14, CD15, CD16+CD56+ (both stained together), CD34, CD41, CD45RA, CD56, and CD90. Cells are intended to enhance reconstitution in hematopoietic stem cell transplantation patients with high risk of iatrogenic conditioning-related prolonged pancytopenia.

Поделиться этой страницей